Rhinosinusitis is the inflammation of the mucous membranes of nose and paranasal sinus(es). 5–13% of upper respiratory tract infections in children complicate into acute rhinosinusitis. Though not life threatening, it profoundly affects child’s school performance and sleep pattern. If untreated, it could progress to chronic rhinosinusitis (CRS). The pathogens involved in perpetuation of CRS consist of multidrug-resistant mixed microflora. CRS is challenging to manage and could further extend to cause eye or intracranial complications. In children, CRS diagnosis is often either missed or incomprehensive. Due to this, morbidity and strain on healthcare budget are tremendous. Flexible fiberoptic endoscopy has revolutionized management of CRS. Its utility in children is being increasingly recognized. Optimal management entails specific appropriate antimicrobials as well as treatment of underlying causes. The aim is to normalize sinus anatomy and physiology and regain normal mucociliary function and clearance.
1. Introduction
Rhinosinusitis is a widely prevalent disease affecting more than 14% of adults and children [1–4]. It has high propensity to become chronic. Though the acute form of rhinosinusitis is unimicrobial, multiple microorganisms characterize the chronic form [5–7]. The latter microbes usually demonstrate antimicrobial resistance and pose a therapeutic challenge for the practising physician [8]. Fungi often coinhabit such chronically infected sinuses and are extremely difficult to eradicate [9]. They add on to the morbidities and complications [10, 11]. Maximum medical therapy often fails and surgical interventions become mandatory [12, 13]. This wells up healthcare costs. Hence early detection and prompt and appropriate treatment of rhinosinusitis could possibly avert CRS and its individual and societal burden [14, 15].
2. Definition
The combined term “Rhinosinusitis” was coined by 1997 Task Force of Rhinology and Paranasal Sinus Committee because sinusitis is invariably accompanied by rhinitis [16]. Acute rhinosinusitis implies sudden onset of two or more of the following symptoms: nasal discharge, stuffiness or congestion, facial pain/pressure, or anosmia/hyposmia [17, 18]. There may be associated fever, malaise, irritability, headache, toothache, or cough. When symptoms are present for 4–12 weeks, it is subacute rhinosinusitis. When they persist for more than 12 weeks, it is termed as “chronic rhinosinusitis” [19]. The latter results usually due to untreated/improperly treated/refractory acute rhinosinusitis. Recurrent rhinosinusitis is 4 or more episodes of acute sinus infection in one year with each episode lasting for about a week. Based on the etiology, rhinosinusitis could be viral, bacterial, fungal, parasitic, or mixed.
3. Development and Anatomy of Paranasal Sinuses
Paranasal sinuses are air-filled hollows in the skull bones connected to the nose. Ethmoid and maxillary sinuses are present at birth and fully developed by 3 years. The development of sphenoidal sinus starts by 3 years and that of frontal sinus by 7 years; these are fully developed only by adolescence [20]. Sinuses have multiple functions; the most important of which is humidification and heating of inspired air, providing vocal resonance, lightening of skull bones, immune defence, and absorption of pressure variations [21, 22]. They are lined by mucous membrane made up of pseudostratified ciliated columnar epithelium with interspersed mucus-secreting goblet cells. This lining is in continuation with that of the nasal cavity. The sinus cavity is normally sterile. Its secreted mucus contains antimicrobicidal polypeptides and lipids which function as innate defence for the airways [23]. The continuous movements of the cilia towards the sinus orifice generate currents which clear the mucus from the sinus into the nasal cavity [24]. The main area of sinus drainage is the “ostiomeatal complex” present in the middle meatus on the lateral wall of the nasal cavity (Figure 1) [25]. Its borders and margins are ill-defined and it is more of a functional area for opening of the anterior ethmoid, maxillary, and frontal sinuses. It comprises maxillary ostia, infundibulum, uncinate process, hiatus semilunaris, ethmoid bulla, and middle meatus [26].
4. Etiopathogenesis
The integrity of the ostiomeatal complex is most crucial for sinus health. Ostial obstruction is usually the start point for sinusitis. It generates a negative pressure in the sinus, which leads to fluid seepage into the sinus. This fluid being a good culture media gets easily infected. This damages the lining cilia, and mucus production is increased. Mucociliary clearance thus gets compromised. A self-perpetuating cycle is established, which needs to be interrupted for optimal outcome [27]. One or more sinuses may be involved with infection. Isolated sphenoidal sinusitis is less common being seen in only 2.7% of sinus infections [28]. The “ostiomeatal complex” obstruction could be due to [29, 30]
anatomic abnormalities such as adenoidal hypertrophy, deviated nasal septum, concha bullosa, Haller cells, and so forth [31];
mucosal edema due to viral rhinitis and allergic rhinitis including aspirin sensitivity;
Swimming, diving, high-altitude climbing, and diabetes mellitus predispose to rhinosinusitis [29].
Viruses are most common causes of acute rhinosinusitis [35]. Within few days, bacterial invasion and proliferation set in. Streptococcus pneumonia, Hemophilus influenzae, Moraxella catarrhalis, beta-hemolytic Streptococcus pyogenes are usual pathogens cultured. Mycoplasma and chlamydial species have also been found associated with sinusitis in children [36–38]. With chronicity, polymicrobes supersede [39, 40]. These include staphylococci, alpha-hemolytic streptococci, anaerobes such as peptostreptococci, Bacteroides and Fusobacterium species, pseudomonads, other gram-negative enteric bacteria, and fungi. Dematiaceous fungi comprising of Bipolaris, Curvularia, Exserohilum, Alternaria, Drechslera, Helminthosporium, Acremonium, Chrysosporium, Fusarium and Aspergillus species are commonly isolated from CRS [41, 42]. Paecilomyces lilacinus is a rare cause of sinusitis in immunocompetent host [43]. Trichoderma longibrachiatum and Ulocladium have been recovered in some cases [44, 45]. Parasites as a cause of sinusitis are extremely rare and commonly encountered in those with immune disorders [46–49].
CRS is usually a consequence of untreated, improperly treated, or nonresponding acute rhinosinusitis. Entry of aerosolized environmental fungi into sinuses of children with allergic rhinitis could also initiate allergic fungal sinusitis (AFS). Fungal debris and thick, tenacious, and highly viscous allergic mucin are hallmarks of AFS. Allergic mucin is lamellated collection of inspissated inflammatory debris. These specific sinal secretions are either light brown to dark green in color and have been variously described as peanut butter or axle grease. In AFS, tissue invasion is absent, and marked eosinophilia with raised serum total IgE is noticed. It is an immunologically mediated disease with predominant Th2 type of immune response. The signature cytokines of this Th2 type of immune response, namely IL-4, IL-5, and IL-13, are raised in sinonasal fluids [50]. Researchers from Hopkins have found that the gene for acidic mammalian chitinase (AMCase) enzyme is more than 250 times active in CRS. This is assumed to be due to misplaced immunity to “ghost” organisms [51]. CRS also has rampant biofilm formation. Biofilms are structured, specialized, complex aggregates of adherent microorganisms encased in matrix or extracellular polymeric substance [52]. They are the sessile, metabolically inactive phenotype of bacteria/fungi which have adopted this state for survival. They are characterized by genetic diversity, structural heterogeneity, surface attachment, complex community interactions, and an extracellular matrix of polymeric substances. They cover more than 90% of the sinus mucosa in CRS. Adenoidal tissue, tonsils, otitis media, and cholesteatomas also demonstrate biofilms. These areas serve as nidus to propagate the virulent infection [53, 54]. Biofilms are multispecies community and this diversity helps organisms to gain a competitive advantage over antibiotics and host’s defences. The germs continue to flourish in these biolayers and their close proximity in high numbers facilitates transfer of genetic material for antimicrobial resistance. This coupled with recurrent irrational antibiotic courses further promotes development of resistance. In many instances, in spite of in vitro sensitivity, in vivo resistance is seen. Biofilms thus serve as an effective survival strategy [55–57]. Microcolonies with well-developed channels to convey fluids and nutrients are seen in these biofilms [58]. Scanning electron microscopy (SEM), transmission electron microscopy (TEM), and confocal laser scanning microscopy (CLSM) with staining for live/dead organisms or fluorescent in-situ hybridization (FISH) are used to detect these biofilms [59–61]. Since sinus mucosa is directly adherent to bone, spread of infection to bones and osteitis is frequent; it is seen in 36–53% of cases of CRS in adults [62]. This could further extend to the adjacent skull, brain, or eyes [63].
Thus, CRS is predominantly a heterogeneous inflammatory disease. It is multifactorial with environmental and host general and anatomic factors all playing a role in its development. Persistence of infection (biofilms and osteitis), allergy, immunologic disorders, upper airway intrinsic factors, superantigens-induced polyclonal immune response, fungi with eosinophilic inflammation, remodeling, and metabolic problems such as aspirin sensitivity all contribute to the varied picture of chronic rhinosinusitis [64]. It is a tough disease to manage and demonstrates multiple recurrences.
5. Clinical Features
Rhinosinusitis usually starts with an acute upper airway infection which persists beyond 7–10 days. The cold either does not improve, worsens after 7–10 days, or returns after an initial improvement (double sickening). It is also called “head cold.” It is associated with fever, malaise, irritability, facial pain or pressure, headache, cough, rhinorrhoea, nasal stuffiness, and diminution or loss of olfactory sensations. There may be postnasal drip, halitosis, and otitis media. With severe infection, purulent nasal secretions, high fever, and periorbital edema are seen [65]. Some may evolve into bacterial or persistent forms. However, the majority of acute infections resolve without antibiotics. Some of these resolved cases may recur as acute or subacute rhinosinusitis [66]. Anterior rhinoscopy usually reveals hypertrophied, red and inflamed inferior turbinate, nasal polyp, or pus at middle meatus. The latter can be better visualized with nasal endoscopy which may, however, be difficult in younger and uncooperative patients. This telescopic visualization can also detect adenoidal hypertrophy, foreign bodies, and other obstructions [67]. Eye or meningeal/brain infections may tag on with CRS. These polymicrobial infections have high morbidity and require urgent surgical interventions.
Allergic fungal sinusitis comprises 5–10% of CRS. It is common in older immunocompetent children with no sex predilection. It differs from invasive fungal infections of paranasal sinuses of immunodeficient patients in its noninvasive nature, eosinophilia, and presence of allergic mucin. Features of AFS are similar to CRS except that pain is not common in the former. Also there are associated features of allergic rhinitis in AFS. AFS should be suspected when allergic rhinitis is recalcitrant. Proptosis, telecanthus, and malar flattening may be noticed in long-standing cases. Since proptosis is established over time, visual loss or diplopia are rarely associated. Children have commonly unilateral involvement in AFS compared to adults [68]. Sinusitis forms the initiating focus in 50% of the Henoch-Schonlein purpura (HSP) in children [69].
6. Diagnosis
Diagnosis of rhinosinusitis in children is not easy. It should be suspected when cold does not improve beyond 10 days or nasal stuffiness is present with purulent discharge, facial pain, headache, fever, and diminution/loss of sense of smell. Dental, ear, or eye problems, allergies, or environmental pollutants can produce similar symptoms and cause confusion. Sneezing and nasal itching are common with allergic rhinitis. In these children with isolated allergic rhinitis, purulent nasal discharge is usually not seen. In those children of allergic rhinitis with superadded sinusitis, the picture is altered, and along with nasal itching and sneezing, purulent nasal secretions and loss of olfaction sense may also be associated. Allergic rhinitis is not uncommonly seen associated with sinusitis; hence a search for triggering allergies needs to be performed in children presenting with rhinosinusitis. Anterior rhinoscopy and fibreoptic nasal endoscopy may be useful for accurate assessment of the middle meatus pathologies and detection of associated adenoiditis, nasal polyps, or nasal masses. This can also be used to collect specimen for testing secretions or mucosa. Patient cooperation is of utmost importance for these procedures.
Transillumination of sinuses is useful in hands of experienced person. In this, a flashlight is placed against the patient’s cheek and the doctor looks into the patient’s open mouth. A lit-up reddened area is seen in the palatal area with normal sinuses. When sinuses are fluid-filled, this reddened area will not be visualized [70]. Near-infrared light (750–1100 nm) can penetrate deeper and permit enhanced illumination of deeper structures. But since this light is invisible normally, a charge-coupled device camera is used to capture and record images. This technique has been found to be a safe, reliable, low-cost, and simple aid for diagnosis of sinusitis [71].
Plain radiography of paranasal sinuses can be performed, but it has a limited diagnostic role. Water and Caldwell-Luc’s views are taken for sinusitis. Haziness, opacification, or fluid level is suggestive of sinusitis [72]. CT scan of sinuses gives a better visualization and is a useful tool preoperatively. Limited axial and coronal cuts ordinarily suffice. Contrast is reserved for suspected suppuration. CT scan can pick up noninvasively ostiomeatal anomalies with great accuracy. Mucosal changes, intrasinus collections or growths, and adjacent bone changes can be visualized. Soft-tissue algorithms of CT scan reveal heterogeneity of signal intensity in AFS. Accumulations of heavy metals (iron, manganese, calcium) within the allergic mucin elicit enhanced signals. For orbital and intracranial extensions or in AFS, MRI is more informative. In AFS, allergic mucin is hyperdense on T1W1 images with signal void on T2 imaging [72–74]. USG can be used for assessment of maxillary sinuses, but results are found to be inconsistent [75].
In acute cases, complete blood count, ESR, and blood cultures provide useful data. Tests for allergy, immunodeficiency, cystic fibrosis, and immotile cilia syndrome assist to detect associated conditions [76–78]. In AFS, total serum IgE and skin or in vitro tests for fungi and common allergens are usually positive [79, 80]. For collection of specimen for culture from the maxillary sinus, a maxillary sinus puncture is the standard criterion. However, it is painful, needs patient cooperation, and can be done only under anaesthesia in children. Culture swabs obtained from middle meatus or anterior middle turbinate correlate well with cultures from maxillary or ethmoid sinuses. However, random nasal swab cultures bear no correlation with maxillary sinus cultures. Gram-staining, aerobic and anaerobic cultures, and fungal cultures can be performed on the collected swabs to guide appropriate antimicrobial therapy. Flexible endoscopes are also employed for such specimen collections. Biopsy taken during endoscopic sinus procedures shows submucosal inflammatory infiltrates in acute and chronic rhinosinusitis. In AFS, eosinophils and Charcot-Leyden crystals predominate [81]. A positive fungal culture grown from infected sinuses is not confirmative of allergic fungal sinusitis. The isolated fungi may be a saprophyte, or the method of specimen collection and handling may also influence the yield. Presence of allergic mucin is a reliable pointer towards the disease [82].
7. Management7.1. Conservative
An acute attack of rhinosinusitis is usually self-limiting and recovers with symptomatic treatment and with minimal intervention. Steam inhalation, adequate hydration, instillation of topical decongestants, warm facial packs application, and saline nasal drops are useful. Elevation of head while sleeping gives relief. The nasal decongestants decrease mucus production and can be safely used for 5–7 days. Extended use beyond this period may lead to rebound vasodilatation and worsening of nasal stuffiness [83]. The study by McCormick et al., however, did not show any benefit of topical decongestant with oral antihistamine in children with acute rhinosinusitis [84]. Nasal saline irrigations, nasal steroids, and topical cromolyn have been found to be useful. The saline irrigations assist to mechanically clear secretions, minimize bacterial and allergen burden, and improve mucociliary function [85]. Nasal steroidal or cromolyn drops or sprays improve symptoms in children with concurrent nasal allergy. Short burst of systemic steroids is employed preoperatively to minimize intraoperative blood loss in children with nasal polyp [86]. Antihistamines are beneficial in those with associated nasal allergy. But they have a tendency to inspissate the secretions and further worsen rhinitis and ostial obstruction. Mucolytics have been noticed to have variable effects. No proper randomized and controlled studies have been performed to evaluate their efficacy in such patients [87, 88]. Environmental pollutants worsen the situation, and hence avoidance of them tends to improve rhinosinusitis [89]. Antibiotics are usually not warranted. A “wait-and-watch” policy for 7–10 days is fruitful and cost-effective. About 90% recover without antibiotics in a week [90]. Antibiotics are reserved for children with severe acute sinusitis, toxic features, suspected complications, or persistence of symptoms [91]. Choice of antibiotics should be guided by local susceptibility studies, safety profile, and child’s age. Usual preferred are amoxicillin, coamoxiclav, oral cephalosporins, and macrolide group of antibiotics. 2 weeks course is usually required [92]. Associated conditions should be simultaneously and individually addressed as follows.
Respiratory allergy. Allergen avoidance, environmental control, topical nasal steroids, second-generation antihistamine, leukotriene receptor antagonist, and immunotherapy are common measures to control allergic rhinitis. Immunotherapy is valuable for children with known allergens that cannot be avoided and where conservative therapy has not been advantageous. Anti-IgE therapy has been found to provide clinical benefit in patients with seasonal allergic rhinitis [93, 94]. Inhaled bronchodilators and optimal use of steroids could control bronchial asthma. Removal of trigger factors from the environment or diet also aid in minimizing asthmatic attacks. Active and/or passive smoking should be curtailed.
Gastroesophageal reflux. Elevation of the head end of bed, small, frequent and thickened feeds, avoiding near-bedtime feeds, H2-blockers, prokinetic agents, and hydrogen ion pump inhibitors are used to control reflux [95].
Cystic fibrosis. Nasal irrigations, nasal steroids, antibiotic courses, nebulized antibiotics, chest physiotherapy, and exercises aid to clear the copious secretions and thwart infections [96].
Immunodeficiencies. Aggressive treatment of recurrent infections and regular immunoglobulin infusions could control secondary infections in such patients [97].
Immotile cilia syndrome. This requires vigorous removal of secretions which in turn causes a decline in infection rate and associated complications [98].
Removal or correction of nasal obstructions.
Since CRS harbours extended-spectrum β-lactamase- (ESBL-) producing multi-drug-resistant polymicrobes, a broad-spectrum β-lactamase-stable second-line antibiotic is preferred as the first choice [99]. Antibiotics with activity against aerobic and anaerobic ESBL-producing bacteria and group A β-hemolytic streptococci (GABHS) will be able to provide clinical and microbiological clearance. Lincomycin, clindamycin, coamoxiclav, metronidazole with a macrolide, fluoroquinolone, aminoglycoside, expanded-spectrum cephalosporins, or carbapenems are usually effective [7, 100]. The therapy could be later deescalated based on susceptibility tests. This lessens chances of increasing resistance. Cefuroxime, cefpodoxime, cefdinir, vancomycin, clindamycin, and antipseudomonal antibiotics are all useful for polymicrobial infections. Parenteral therapy may be required in severe resistant cases [101]. Though there is no grade 1 evidence to support antibiotic usage in CRS in children, antibiotics are often used to treat CRS in children. Duration of therapy is for 3–6 weeks. Improvement in symptoms was seen after 22.35±5.04 days (mean) of antibiotic treatment [102, 103]. The role of long-term intravenous antibiotics for CRS is not universally established, though a subset of CRS may benefit from such therapy [104]. Topical antibiotics have also been tried with varied results. Various modes of drug delivery are employed with ongoing research to enhance the drug delivery and deposition into the sinuses [105]. Prolonged low-dose oral antibiotics were found to be beneficial for CRS, but more studies are needed before recommending it as standard treatment [106]. Saline nasal irrigation is useful as adjuvant therapy in CRS and is found to be well tolerated in children [107, 108]. Since biofilm formation is the rule in CRS, modulation of the matrix and novel methods of biofilm disruption may be tried [109–113]. Drugs targeted against production or action of the AMCase enzyme could be fruitful in the management of persistent and recurrent sinus infections [43]. Oral enzymes such as rutin and bromelain are useful as adjunctive therapy [114]. Some traditional ayurvedic decoctions such as Pitawakka Navaya are relatively safe and useful as supplementary treatment in chronic sinusitis [115]. In AFS, it is difficult to remove the thick fungal debris and mucin in the sinal cavity. Surgical cleansing, antifungal medicines, steroids, and immunotherapeutic measures are used to achieve eradication with variable success [116]. Followups of cases with immunotherapy showed no recurrence after 7–17 months [117].
7.2. Surgical
Adenoidectomy is usually the first surgical intervention considered for children with CRS. It removes the obstruction as well nidus of infection [118–121]. A risk-benefit analysis should be carried out before considering other surgical approaches in children. There has been major transformation in diagnosis and therapy of rhinosinusitis due to the technical advances in medical endoscopes. When appropriate, maximal medical therapy fails or with associated anatomic aberrations, surgical interventions are contemplated in rhinosinusitis. About 2/3rd of patients of CRS fail maximal medical therapy and need to go ahead with surgery [122]. Almost universally, children with diagnosis of AFS need operative intervention, postoperative medical management, and close long-term monitoring and followup [123]. Surgery aims to restore sinus ventilation and ciliary function. Functional endoscopic sinus surgery (FESS) is done via a flexible endoscope and is beneficial for management of chronic sinusitis. However, in children, it is reserved only for complicated cases. FESS can remove the thick tenacious secretions, debris, and mucin in allergic fungal sinusitis which are otherwise difficult without open surgical methods. Detergent, 1% solution in normal saline of Johnson and Johnson baby shampoo, topical antibiotics such as gentamycin/tobramycin or antifungal drugs, and tea or sinufresh could be used during surgery to irrigate the sinus and improve outcomes [124–127] Baby shampoo contains a zwitterionic surfactant, which disrupts the biofilm. This could also be used for nasal irrigation post surgery [126]. Naraghi et al. found that the quality of life was improved significantly in patients after FESS [128]. FESS should be done with great care especially in those with AFS because in them bone dissolution is common and there is a potential risk of inadvertent penetration into orbit or cranium [129]. Animal studies have shown that even limited surgeries could affect sinus and facial growths. Hence FESS in children should be considered only after weighing the pros and cons of the procedure [130].
Other more invasive surgical techniques for maxillary sinusitis include antral washout, natural ostotomy, intranasal inferior meatal antrostomy (INA, nasoantral window), middle meatal antrostomy, Caldwell-Luc’s operation (intraoral maxillary antrostomy), and uncinectomy (with or without endoscope and with or without maxillary antrostomy). All of these operations have their own indications, limitations, and problems [131–133]. Natural ostotomy and INA have been compared in rabbits and found to have similar outcome results [134]. Such comparisons unfortunately have not been studied in humans or children. Endoscopic middle meatal antrostomy has been shown to be better for maxillary sinusitis compared to the Caldwell-Luc operation [131]. Mycetomas and fungal balls in chronic rhinosinusitis also often require surgical debridement [135]. Intranasal antifungals have been studied and found to be of benefit for fungal chronic sinusitis; however, Cochrane analysis has shown no significant usefulness of topical or systemic antifungals over placebo for chronic sinusitis [136, 137]. Balloon sinuplasty is a new procedure in which ostia are dilated with the help of balloons. It could be tried before FESS for those who fail to respond to medical treatment and have minimal anatomic findings on CT scan [138]. A comparative outcome analysis of FESS alone versus balloon catheter sinuplasty in pediatric CRS revealed that both have similar outcomes, but antibiotics were required significantly lesser in the balloon catheter sinuplasty group [139].
8. Management of Complications
Intraorbital and intracranial complications are common in chronic sinusitis, and fungal sinusitis and with cystic fibrosis and immunodeficient states [140, 141]. Meningitis, abscess, and cavernous sinus thrombosis may occur. Sinusitis may extend to adjacent tissues and cause adenoiditis, serous or purulent otitis media, laryngitis, and dacryocystitis. Osteomyelitis and mucocele formation are also noted. Hospitalization and intravenous antibiotics may be required for treatment of these complications. Resistance rates are higher in complicated cases and culture-targeted antimicrobial therapy may be more beneficial for early resolution of symptoms. Prolonged course of antibiotics for 4–6 weeks may be necessitated in them. Cerebral venous thrombosis needs anticoagulation [142]. Nasal decongestants and steroids and nasal saline irrigation may be required for a longer time in such patients even after cessation of antimicrobial therapy. Pollutants, irritants, and allergens in the environment increase symptoms and avoidance of them is of benefit. Specific immunotherapy will be advantageous in cases where allergens cannot be avoided. Aggressive management of acute attacks will preserve mucosal integrity and ciliary function. Dental management for odontogenic sinusitis should be performed and children with sinusitis-associated HSP should be managed appropriately [143, 144].
9. Prognosis
Prognosis depends on stage of rhinosinusitis, associated conditions, rate of complications, type and severity of infection, host factors, environmental factors, compliance with treatment, and treatment modality employed [145]. Acute rhinosinusitis if managed well has potential to recover with no sequelae. Recurrence rate would be lower if associated conditions are rectified simultaneously and negative environmental factors are eliminated. Once CRS sets in, prognosis is guarded. Work productivity and quality of life are lessened. Early and aggressive treatment could give satisfactory outcomes and avert complications.
10. Prevention
As a general rule, prevention of risk factors can help avoid development of rhinosinusitis. These include environmental pollutants including tobacco smoke, repeated colds and upper airway infections, daycare centre attendance, nasal allergies, and anatomical aberrations. These should be managed on a war footing in order to avoid their development into rhinosinusitis. Acute attacks of rhinosinusitis should be optimally managed to prevent progress to chronicity [146]. Prevention of adhesion and inhibition of quorum signalling may diminish biofilm formation and its associated problems of nonresponse to medical line of treatment [147]. Influenza and pneumococcal vaccines could also lead to fall in upper airway infections and hence rhinosinusitis [148]. Swimming in pools with high chlorine content may also worsen mucosal swelling and lining. Hence care should be taken at such places. Frequent plane flyers may also see worsening of symptoms with flights and precautions during such flights may help [149, 150].
11. Conclusions
Rhinosinusitis is an upper airway infection with chronic implications. Prompt management of acute cases would prevent cases slipping into chronicity with resistant polymicrobial infections. Management of chronic rhinosinusitis is an expensive, long-term affair with high likelihood of complications. Hence prevention and control of rhinosinusitis will assist in decreasing morbidity and lessen the burden on healthcare expenditure. Achieving sinonasal eutrophism and efficient mucociliary transport is the keystone to sinus health and reduction of recurrences.
BruijnzeelsM. A.FoetsM.Van Der WoudenJ. C.Van Den HeuvelW. J. A.PrinsA.Everyday symptoms in childhood: occurrence and general practitioner consultation rates1998484268808842-s2.0-0031962970MasoodA.MoumoulidisI.PanesarJ.Acute rhinosinusitis in adults: an update on current management2007839804024082-s2.0-3425074785310.1136/pgmj.2006.054767SchappertS. M.Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 199619981341372-s2.0-0031993611PooleM. D.A focus on acute sinusitis in adults: changes in disease management19991065 A2-s2.0-0033519365BielM. A.BrownC. A.LevinsonR. M.GarvisG. E.PaisnerH. M.SigelM. E.TedfordT. M.Evaluation of the microbiology of chronic maxillary sinusitis1998107119429452-s2.0-0031733760BrookI.FrazierE. H.FooteR. A.Microbiology of the transition from acute to chronic maxillary sinusitis19964553723752-s2.0-0029804168BrookI.Microbiology and antimicrobial management of sinusitis20043722532662-s2.0-184247720510.1016/S0030-6665(03)00155-5WaldE. R.BordleyW. C.DarrowD. H.GrimmK. T.GwaltneyJ. M.Jr.MarcyS. M.Senac M. O.Jr.WilliamsP. V.Clinical practice guideline: management of sinusitis200110837988082-s2.0-0035166524DeShazoR. D.Fungal sinusitis1998316139452-s2.0-003182479110.1097/00000441-199807000-00006McCormickA.FlemingD.CharltonJ.1995London, UKHMSOBenningerM. S.Rhinitis, sinusitis and their relationship to allergy199263743WelchK. C.StankiewiczJ. A.A contemporary review of endoscopic sinus surgery: techniques, tools, and outcomes200911911225822682-s2.0-7344911930010.1002/lary.20618LieserJ. D.DerkayC. S.Pediatric sinusitis: when do we operate?200513160662-s2.0-1324426988810.1097/00020840-200502000-00014PleisJ. R.ColesR.Summary health statistics for U.S. adults: National Health Interview Survey, 1999200321211372-s2.0-4944231573RayN. F.BaraniukJ. N.ThamerM.RinehartC. S.GergenP. J.KalinerM.JosephsS.PungY. H.Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders199910334084142-s2.0-0033017152Report of the Rhinosinusitis Task Force Committee Meeting. Alexandria, Virginia, August 17, 199619971173 Pt 2S1S68LanzaD. C.KennedyD. W.Adult rhinosinusitis defined19971173, part 2S1S72-s2.0-0030820376FokkensW.LundV.BachertC.ClementP.HelllingsP.HolmstromM.JonesN.KalogjeraL.KennedyD.KowalskiM.MalmbergH.MullolJ.PassaliD.StammbergerH.StiernaP.EAACI position paper on rhinosinusitis and nasal polyps executive summary20056055836012-s2.0-2024438270910.1111/j.1398-9995.2005.00830.xBenningerM. S.FergusonB. J.HadleyJ. A.HamilosD. L.JacobsM.KennedyD. W.LanzaD. C.MarpleB. F.OsguthorpeJ. D.StankiewiczJ. A.AnonDennenyJ.EmanuelI.LevineH.Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology20031293S1S322-s2.0-014192799210.1016/S0194-5998(03)01397-4WolfG.AnderhuberW.KuhnF.Development of the paranasal sinuses in children: implications for paranasal sinus surgery199310297057112-s2.0-0027448826BaroodyF. M.Nasal and paranasal sinus anatomy and physiology2007191212-s2.0-36448995523WateletJ. B.Van CauwenbergeP.Applied anatomy and physiology of the nose and paranasal sinuses199954supplement 5714252-s2.0-0032745449LeeJ. T.JansenM.YilmaA. N.NguyenA.DesharnaisR.PorterE.Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis2010242991042-s2.0-7795089150810.2500/ajra.2010.24.3444WagenmannM.NaclerioR. M.SpectorS. L.Anatomic and physiologic considerations in sinusitis1992903, part 24194232-s2.0-0026646257GotwaldT. F.ZinreichS. J.CorlF.FishmanE. K.Three-dimensional volumetric display of the nasal ostiomeatal channels and paranasal sinuses200117612412452-s2.0-0035189242MomeniA. K.RobertsC. C.ChewF. S.Imaging of chronic and exotic sinonasal disease: review20071896S35S452-s2.0-3644896893010.2214/AJR.07.7031StevensH. E.Allergic and inflammatory aspects of chronic rhinosinusitis19912063953992-s2.0-0026355192NgY. T.ButlerI. J.Sphenoid sinusitis masquerading as migraine headaches in children200116128828842-s2.0-0035569224Ah-SeeK. W.EvansA. S.Sinusitis and its management200733475893583612-s2.0-3384711214710.1136/bmj.39092.679722.BEOrlandiR. R.KennedyD. W.Surgical management of rhinosinusitis1998316129382-s2.0-003187434710.1097/00000441-199807000-00005MilczukH. A.DalleyR. W.WessbacherF. W.RichardsonM. A.Nasal and paranasal sinus anomalies in children with chronic sinusitis199310332472522-s2.0-0027509113ShapiroG. G.VirantF. S.FurukawaC. T.PiersonW. E.BiermanC. W.Immunologic defects in patients with refractory sinusitis19918733113162-s2.0-0025978326GilgerM. A.Pediatric otolaryngologic manifestations of gastroesophageal reflux disease2003532472522-s2.0-0037828977KretzschmarD. P.KretzschmarC. J. L.Rhinosinusitis: review from a dental perspective20039621281352-s2.0-004209039410.1016/S1079-2104(03)00306-8OsguthorpeJ. D.HadleyJ. A.Rhinosinusitis: current concepts in evaluation and management199983127412-s2.0-003289413710.1016/S0025-7125(05)70085-7SavolainenS.Jousimies-SomerH.KleemolaM.YlikoskiJ.Serological evidence of viral or Mycoplasma pneumoniae infection in acute maxillary sinusitis1989821311352-s2.0-0024560603CultraraA.GoldsteinN. A.OvchinskyA.ReznikT.RoblinP. M.HammerschlagM. R.The role of Chlamydia pneumoniae infection in children with chronic sinusitis200312910109410972-s2.0-014192646110.1001/archotol.129.10.1094ConradD. A.JensonH. B.Management of acute bacterial rhinosinusitis200214186902-s2.0-003618216410.1097/00008480-200202000-00015WaldE. R.Microbiology of acute and chronic sinusitis in children and adults1998316113202-s2.0-003182583910.1097/00000441-199807000-00003ChanJ.HadleyJ.The microbiology of chronic rhinosinusitis: results of a community surveillance study20018031431452-s2.0-0035102572OrobelloP. W.ParkR. I.BelcherL. J.EgglestonP.LedermanH. M.BanksJ. R.ModlinJ. F.NaclerioR. M.Microbiology of chronic sinusitis in children199111799809832-s2.0-0025916095ManningS. C.VuitchF.WeinbergA. G.BrownO. E.Allergic aspergillosis: a newly recognized form of sinusitis in the pediatric population1989997 I6816852-s2.0-0024323439PermiH. S.KumarY.KarnakerV. K.KishanP. H. L.TeerthanathS.BhandaryS. K.A rare case of fungal maxillary sinusitis due to Paecilomyces lilacinus in an immunocompetent host, presenting as a subcutaneous swelling2011314648TangP.MohanS.SiglerL.WitterickI.SummerbellR.CampbellI.MazzulliT.Allergic fungal sinusitis associated with Trichoderma longibrachiatum20034111533353362-s2.0-024259375910.1128/JCM.41.11.5333-5336.2003KaurR.WadhwaA.GulatiA.AgrawalA. K.An unusual phaeoid fungi: Ulocladium, as a cause of chronic allergic fungal sinusitis20102295972-s2.0-77956993309DicksonJ. M.ZetlerP. J.WalkerB.JaverA. R.Acanthamoeba rhinosinusitis2009383E87E902-s2.0-6704916490110.2310/7070.2009.080157OudL.Trichomonal sinusitis in an adolescent patient with multiple trauma200910233303322-s2.0-6314911917410.1097/SMJ.0b013e318182f392DuqueC. S.MosqueraC. A.CasianoR. R.AbreuC. E.Radiologic findings in sinonasal myiasis200613546386392-s2.0-3374895370410.1016/j.otohns.2005.04.012NachegaJ. B.RombauxP.WeynandB.ThomasG.ZechF.Successful treatment of Acanthamoeba rhinosinusitis in a patient with AIDS200519106216252-s2.0-2734444419110.1089/apc.2005.19.621ElhiniA.AbdelwahabS.IkedaK.Th1 and Th2 cell population in chronic ethmoidal rhinosinusitis: a chemokine receptor assay20051157127212772-s2.0-2184444505010.1097/01.MLG.0000165380.64445.EERamanathanM.LeeW. K.LaneA. P.Increased expression of acidic mammalian chitinase in chronic rhinosinusitis with nasal polyps20062033303352-s2.0-3374617751210.2500/ajr.2006.20.2869HarveyR. J.LundV. J.Biofilms and chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research20074513132-s2.0-33947635022PostJ. C.StoodleyP.Hall-StoodleyL.EhrlichG. D.The role of biofilms in otolaryngologic infections20041231851902-s2.0-254246255810.1097/01.moo.0000124936.46948.6aZulianiG.CarronM.GurrolaJ.ColemanC.HaupertM.BerkR.CoticchiaJ.Identification of adenoid biofilms in chronic rhinosinusitis2006709161316172-s2.0-3374687040410.1016/j.ijporl.2006.05.002CostertonJ. W.ChengK. J.GeeseyG. G.LaddT. I.NickelJ. C.DasguptaM.MarrieT. J.Bacterial biofilms in nature and disease1987414354642-s2.0-0023463796GafanG. P.SprattD. A.Denaturing gradient gel electrophoresis gel expansion (DGGEGE)—an attempt to resolve the limitations of co-migration in the DGGE of complex polymicrobial communities200525323033072-s2.0-2794444240510.1016/j.femsle.2005.09.048MahenthiralingamE.CampbellM. E.SpeertD. P.Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis19946225966052-s2.0-0028012203StoodleyP.DeBeerD.LewandowskiZ.Liquid flow in biofilm systems1994608271127162-s2.0-0028085605Ramírez-CamachoR.González-TallónA. I.GómezD.TrinidadA.IbáñezA.García-BerrocalJ. R.VerdaguerJ. M.González-GarcíaJ. Á.San RománJ.Environmental scanning electron microscopy for biofilm detection in tonsils200859116202-s2.0-3904915331510.1016/S0001-6519(08)73252-7ReeseS.GuggenheimB.A novel TEM contrasting technique for extracellular polysaccharides in in vitro biofilms20077098168222-s2.0-3484884405610.1002/jemt.20471LawrenceJ. R.NeuT. R.Confocal laser scanning microscopy for analysis of microbial biofilms19993101311442-s2.0-003269892810.1016/S0076-6879(99)10011-9LeeJ. T.KennedyD. W.PalmerJ. N.FeldmanM.ChiuA. G.The incidence of concurrent osteitis in patients with chronic rhinosinusitis: a clinicopathological study20062032782822-s2.0-3374617883710.2500/ajr.2006.20.2857ChiuA. G.Osteitis in chronic rhinosinusitis2005386123712422-s2.0-2844449975610.1016/j.otc.2005.07.007van CrombruggenK.ZhangN.GevaertP.TomassenP.BachertC.Pathogenesis of chronic rhinosinusitis: inflammation20111284728732BrookI.GoochW. M.IIIJenkinsS. G.PichicheroM. E.Medical management of acute bacterial sinusitis: recommendations of a clinical advisory committee on pediatric and adult sinusitis200010952202-s2.0-0342803642RiceD. H.Endoscopic sinus surgery19932646136182-s2.0-0027282351LowD. E.DesrosiersM.McSherryJ.GarberG.WilliamsJ. W.RemyH.FentonR. S.ForteV.BalterM.RotsteinC.CraftC.DuboisJ.HardingG.SchlossM.MillerM.McIvorR. A.DavidsonR. J.A practical guide for the diagnosis and treatment of acute sinusitis1997156supplement 6S1S142-s2.0-0030893623McClayJ. E.MarpleB.KapadiaL.BiavatiM. J.NussenbaumB.NewcomerM.ManningS.BoothT.SchwadeN.Clinical presentation of allergic fungal sinusitis in children200211235655692-s2.0-0036120056NakasekoH.UemuraO.NagaiT.YamakawaS.HibiY.YamasakiY.YamamotoM.High prevalence of sinusitis in children with Henoch-Schonlein purpura20112011356263810.1155/2011/562638BrentK.Transillumination and radiography in diagnosing sinusitis20032511314MahmoodU.CerussiA.DehdariR.NguyenQ.KelleyT.TrombergB.WongB.Near-infrared imaging of the sinuses: preliminary evaluation of a new technology for diagnosing maxillary sinusitis20101532-s2.0-7795300775710.1117/1.3431718036011LeoG.TriulziF.IncorvaiaC.Sinus imaging for diagnosis of chronic rhinosinusitis in children2012122136143AprilM. M.ZinreichS. J.BaroodyF. M.NaclerioR. M.Coronal CT scan abnormalities in children with chronic sinusitis199310399859902-s2.0-0027268407MafeeM. F.TranB. H.ChapaA. R.Imaging of rhinosinusitis and its complications: plain film, CT, and MRI20063031651852-s2.0-3374558974510.1385/CRIAI:30:3:165FufezanO.AsavoaieC.Cherecheş PantaP.MihuţG.BursaşiuE.AncaI.IacobD.GocanH.ValeanC.The role of ultrasonography in the evaluation of maxillary sinusitis in pediatrics20101214112-s2.0-79952278589YinE. Z.FrushD. P.DonnellyL. F.BuckleyR. H.Primary immunodeficiency disorders in pediatric patients: clinical features and imaging findings20011766154115522-s2.0-0034992416HuiY.GaffneyR.CrysdaleW. S.Sinusitis in patients with cystic fibrosis199525241911962-s2.0-0029068037CampbellR.Managing upper respiratory tract complications of primary ciliary dyskinesia in children20121213238MabryR. L.ManningS.Radioallergosorbent microscreen and total immunoglobulin E in allergic fungal sinusitis199511367217232-s2.0-002959534210.1016/S0194-5998(95)70011-0MabryR. L.MarpleB. F.MabryC. S.Mold testing by RAST and skin test methods in patients with allergic fungal sinusitis199912132522542-s2.0-003284325310.1016/S0194-5998(99)70180-4Al-SwiahbJ. N.Al-AmmarA.Al-DousaryS. H.Allergic fungal sinusitis in children in Saudi Arabia20072811171117142-s2.0-36949014119LaraJ. F.GomezJ. D.Allergic mucin with and without fungus a comparative clinicopathologic analysis200112511144214472-s2.0-0035175885LinC. Y.ChengP. H.FangS. Y.Mucosal changes in rhinitis medicamentosa200411321471512-s2.0-1242269335McCormickD. P.JohnS. D.SwischukL. E.UchidaT.A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children19963594574602-s2.0-0029781867GeorgitisJ. W.Nasal hyperthermia and simple irrigation for perennial rhinitis: changes in inflammatory mediators19941065148714922-s2.0-0027946098MarpleB. F.Allergic fungal rhinosinusitis: current theories and management strategies20011116100610192-s2.0-0035014625ShaikhN.WaldE. R.PiM.Decongestants, antihistamines and nasal irrigation for acute sinusitis in children201012CD0079092-s2.0-79952199592MacchiA.TerranovaP.CastelnuovoP.Recurrent acute rhinosinusitis: a single blind clinical study of N-acetylcysteine vs ambroxol associated to corticosteroid therapy2012251207217PintoJ. M.NaclerioR. M.Environmental and allergic factors in chronic rhinosinusitis20072025492-s2.0-34250188499WorrallG.Acute sinusitis200854182832-s2.0-38849129891EspositoS.BosisS.BellasioM.PrincipiN.From clinical practice to guidelines: how to recognize rhinosinusitis in children200718supplement 1853552-s2.0-3454829583410.1111/j.1399-3038.2007.00635.xChowA. W.BenningerM. S.BrookI.BrozekJ. L.GoldsteinE. J. C.HicksL. A.PankeyG. A.SeleznickM.VolturoG.WaldE. R.FileT. M.Jr.IDSA clinical practice guideline for acute bacterial rhinosinusitis in
children and adults2012548e72e112VerbruggenK.Van CauwenbergeP.BachertC.Anti-IgE for the treatment of allergic rhinitis—and eventually nasal polyps?2009148287982-s2.0-5174909897110.1159/000155739CasaleT. B.CondemiJ.LaForceC.NayakA.RoweM.WatrousM.McAlaryM.Fowler-TaylorA.RacineA.GuptaN.FickR.Della CioppaG.Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial200128623295629672-s2.0-0035915364VandenplasY.RudolphC. D.Di LorenzoC.HassallE.LiptakG.MazurL.SondheimerJ.StaianoA.ThomsonM.Veereman-WautersG.WenzlT. G.Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)20094944985472-s2.0-7034974279210.1097/MPG.0b013e3181b7f563OomenK. P. Q.AprilM. M.Sinonasal manisfestations in cystic fibrosis20122012778957210. 1155/2012/789572AghamohammadiA.AbolhassaniH.MohammadinejadP.RezaeiN.The approach to children with recurrent infections201211289109SagelS. D.DavisS. D.CampisiP.DellS. D.Update of respiratory tract disease in children with primary ciliary dyskinesia201185438443BrookI.Bacteriology of acute and chronic ethmoid sinusitis2005437347934802-s2.0-2214446522010.1128/JCM.43.7.3479-3480.2005SolerZ. M.OyerS. L.KernR. C.SeniorB. A.KountakisS. E.MarpleB. F.SmithT. L.Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendationsInternational Forum of Allergy & Rhinology. In press10.1002/alr.21064JonesN. S.Current concepts in the management of paediatric rhinosinusitis19991131192-s2.0-0032971794MandalR.PatelN.FergusonB. J.Role of antibiotics in sinusitis2012252183192PoachanukoonO.NanthapisalS.ChaumrattanakulU.Pediatric acute and chronic rhinosinusitis: comparison of clinical characteristics and outcome of treatment2012302146151TannerS. B.FowlerK. C.Intravenous antibiotics for chronic rhinosinusitis: are they effective?2004121382-s2.0-164252071410.1097/00020840-200402000-00003AlbuS.Novel drug-delivery systems for patients with chronic rhinosinusitis20126125132VidelerW. J.van HeeK.ReinartzS. M.GeorgalasC.van der MeulenF. W.FokkensW. J.Long-term low-dose antibiotics in recalcitrant chronic rhinosinusitis: a retrospective analysis20125014555JeffeJ. S.BhushanB.SchroederJ. W.Jr.Nasal saline irrigation in children: a study of compliance and tolerance2012763409413WeiJ. L.SykesK. J.JohnsonP.HeJ.MayoM. S.Safety and efficacy of once-daily nasal irrigation for the treatment of pediatric chronic rhinosinusitis2011121919892000CostertonJ. W.EllisB.LamK.JohnsonF.KhouryA. E.Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria19943812280328092-s2.0-0028149475WattanakaroonW.StewartP. S.Electrical enhancement of Streptococcus gordonii biofilm killing by gentamicin20004521671712-s2.0-003414234710.1016/S0003-9969(99)00132-6PittW. G.McBrideM. O.LuncefordJ. K.RoperR. J.SagersR. D.Ultrasonic enhancement of antibiotic action on gram-negative bacteria19943811257725822-s2.0-0028131883RediskeA. M.RoederB. L.BrownM. K.NelsonJ. L.RobisonR. L.DraperD. O.SchaaljeG. B.RobisonR. A.PittW. G.Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model1999435121112142-s2.0-0032938426KarosiT.SziklaiI.CsomorP.Low-frequency ultrasound for biofilm disruption in chronic rhinosinusitis with nasal polyposis: in vitro pilot studyThe Laryngoscope. In press10.1002/lary.23633ShahidS.Role of systemic enzymes in infections201231WMC002504MaragalawaththaM. G.EdiriweeraE. R.ChandimarathneP. B.A clinical trial of Sri Lankan traditional decoction of Pitawakka Navaya in treatment of Kaphaja Shirsha Shoola (chronic sinusitis)2010312193196KumarN.BerryV.Allergic fungal sinusitis2008101582-s2.0-58649111714MabryR. L.MarpleB. F.MabryC. S.Outcomes after discontinuing immunotherapy for allergic fungal sinusitis200012211041062-s2.0-0033976582ManningS.Surgical intervention for sinusitis in children2001132892962-s2.0-0035352415UngkanontK.DamrongsakS.Effect of adenoidectomy in children with complex problems of rhinosinusitis and associated diseases20046844474512-s2.0-154235729510.1016/j.ijporl.2003.11.016VandenbergS. J.HeatleyD. G.Efficacy of adenoidectomy in relieving symptoms of chronic sinusitis in children199712376756782-s2.0-0030789369CoticchiaJ.ZulianiG.ColemanC.CarronM.GurrolaJ.HaupertM.BerkR.Biofilm surface area in the pediatric nasopharynx: chronic rhinosinusitis vs obstructive sleep apnea200713321101142-s2.0-3384711079510.1001/archotol.133.2.110YoungL. C.StowN. W.ZhouL.DouglasR. G.Efficacy of medical therapy in treatment of chronic rhinosinusitis201231e8e12ThorpB. D.McKinneyK. A.RoseA. S.EbertC. S.Allergic fungal sinusitis in children2012453631642HolborowC. A.Treatment of sinusitis in childhood: the effect of a detergent195771106896922-s2.0-70449184218IsaacsS.FakhriS.LuongA.WhitedC.CitardiM. J.The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects2011251e27e292-s2.0-7955155541510.2500/ajra.2011.25.3583ChiuA. G.PalmerJ. N.WoodworthB. A.DoghramjiL.CohenM. B.PrinceA.CohenN. A.Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient200822134372-s2.0-3974908392010.2500/ajr.2008.22.3122DesrosiersM.EvansG. A.KeithP. K.WrightE. D.KaplanA.BouchardJ.CiavarellaA.DoyleP. W.JaverA. R.LeithE. S.MukherjiA.SchellenbergR. R.SmallP.WitterickI. J.Canadian clinical practice guidelines for acute and chronic rhinosinusitis2011402S99S1422-s2.0-7995930868010.2310/7070.2011.100321NaraghiM.AmirzargarB.MeysamieA.Quality of life comparison in common rhinologic surgeries201231e1e7MallickS.SharmaV.LavaniaA.BorgohainB.Allergic fungal sinusitis20086222352382-s2.0-50449084985MairE. A.BolgerW. E.BreischE. A.Sinus and facial growth after pediatric endoscopic sinus surgery199512155475522-s2.0-0029066346JacobK. J.GeorgeS.PreethiS.ArunrajV. S.A comparative study between endoscopic middle meatal antrostomy and
Caldwell-Luc surgery in the treatment of chronic maxillary sinusitis20116332142192-s2.0-7996043993010.1007/s12070-011-0262-2KutluhanA.ŞalvizM.BozdemirK.KanbakO.UluM.YalçinerG.BilgenA. S.The effects of uncinectomy and natural ostial dilatation on maxillary sinus ventilation: a clinical experimental study201126845695732-s2.0-7995594293210.1007/s00405-010-1427-4MuntzH. R.LuskR. P.Nasal antral windows in children: a retrospective study199010066436462-s2.0-0025301267BenningerM. S.KaczorJ.StoneC.Natural ostiotomy vs. inferior antrostomy in the management of sinusitis: an animal model19931096103410422-s2.0-0027729305GrosjeanP.WeberR.Fungus balls of the paranasal sinuses: a review200726454614702-s2.0-3414713385210.1007/s00405-007-0281-5PonikauJ. U.SherrisD. A.WeaverA.KitaH.Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial200511511251312-s2.0-1134426416310.1016/j.jaci.2004.09.037SacksP. L.HarveyR. J.RimmerJ.GallagherR. M.SacksR.Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis2011CD00826310.1002/14651858.CD008263.pub2RamadanH. H.TerrellA. M.Balloon catheter sinuplasty and adenoidectomy in children with chronic rhinosinusitis201011995785822-s2.0-77956375735ThottamP. J.HaupertM.SaraiyaS.DworkinJ.SirigiriR.BelenkyW. M.Functional endoscopic sinus surgery (FESS) alone versus balloon catheter sinuplasty (BCS) and ethmoidectomy: a comparative outcome analysis in pediatric chronic rhinosinusitis201276913551360HakimH. E.MalikA. C.AronykK.LediE.BhargavaR.The prevalence of intracranial complications in pediatric frontal sinusitis2006708138313872-s2.0-3374497054810.1016/j.ijporl.2006.02.003SharmaG. D.DoershukC. F.SternR. C.Erosion of the wall of the frontal sinus caused by mucopyocele in cystic fibrosis19941245 I7457472-s2.0-002822137010.1016/S0022-3476(05)81368-XAbsoudM.HikmetF.DeyP.JoffeM.ThambapillaiE.Bilateral cavernous sinus thrombosis complicating sinusitis20069994744762-s2.0-3374961141310.1258/jrsm.99.9.474PatelN. A.FergusonB. J.Odontogenic sinusitis: an ancient but under-appreciated cause of maxillary sinusitis20122012428InoueC. N.NagasakaT.MatsutaniS.IshidoyaM.HommaR.ChibaY.Efficacy of early dental and ENT therapy in preventing nephropathy in pediatric Henoch-Schönlein purpura20082712148914962-s2.0-5634911976910.1007/s10067-008-0954-5RosenfeldR. M.Pilot study of outcomes in pediatric rhinosinusitis199512177297362-s2.0-0029052980DuseM.CaminitiS.ZicariA. M.Rhinosinusitis: prevention strategies2007181871742-s2.0-3454832269110.1111/j.1399-3038.2007.00639.xHentzerM.GivskovM.Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections20031129130013072-s2.0-034823096210.1172/JCI200320074BenningerM. S.ManzR.The impact of vaccination on rhinosinusitis and otitis media20101064114182-s2.0-7804926195010.1007/s11882-010-0139-6PassàliD.DamianiV.PassàliG. C.PassàliF. M.BellussiL.Alterations in rhinosinusal homeostasis in a sportive population: our experience with 106 athletes200426195025062-s2.0-864423492810.1007/s00405-003-0723-7StewartT. W.Jr.Common otolaryngologic problems of flying19791921131192-s2.0-0018433986